Netpace Inc · 4 months ago
QC Analyst II
Netpace Inc is seeking a QC Analyst II to conduct quality control testing on products and materials. The role involves analyzing test results, ensuring compliance with regulatory standards, and documenting quality control procedures.
AnalyticsArtificial Intelligence (AI)ConsultingEnterprise ApplicationsInformation TechnologyMachine Learning
Responsibilities
Maintain mammalian cell lines, including transferring between incubators
Run plate-based, cell-based assays, and multi-channel assays
Conduct ELISA and BioAssay testing, including different cell cultures
Initiate deviations and perform troubleshooting
Ensure adherence to GMP and QC standards
Work with Veeva document system and other QA record platforms
Knowledge of drug and antibiotic testing at 80°C
Qualification
Required
5–10 years of experience, specifically BioAssay or Cell Culture required
Strong problem-solving skills
Excellent communication abilities
Knowledge of industry best practices
Minimum 5–10 years of experience in GMP environments (3–4 years may be considered if in-depth BioAssay knowledge)
Bachelor's or Master's degree preferred; high school minimum acceptable
Experience with cell culture, maintaining cell lines, ELISA assays, BioAssay, cell-based assays, and different cell cultures
Familiarity with QMS, Nextlab tools, and electronic documentation systems
Experience in assay panel testing and binding/curve analysis
Cell culture – maintain cell lines
ELISA assay
BioAssay
Preferred
Experience with laboratory GMP testing required
Company
Netpace Inc
Netpace is a Data-Driven company excelling in AI, IT Consulting and Staffing Solutions.
H1B Sponsorship
Netpace Inc has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2022 (1)
2020 (2)
Funding
Current Stage
Growth StageCompany data provided by crunchbase